Biopsy News and Research

RSS

Biopsy is the removal of cells or tissues for examination by a pathologist. The pathologist may study the tissue under a microscope or perform other tests on the cells or tissue. There are many different types of biopsy procedures. The most common types include: (1) incisional biopsy, in which only a sample of tissue is removed; (2) excisional biopsy, in which an entire lump or suspicious area is removed; and (3) needle biopsy, in which a sample of tissue or fluid is removed with a needle. When a wide needle is used, the procedure is called a core biopsy. When a thin needle is used, the procedure is called a fine-needle aspiration biopsy.

Clinical trial to evaluate ability of MRI to improve prostate cancer diagnosis

The Movember Foundation, the Ontario Institute for Cancer Research and Prostate Cancer Canada today announced $3 million in funding for a new Phase III clinical trial to evaluate if magnetic resonance imaging (MRI) can replace the current standard of care to diagnose prostate cancer.

2 Jun 2016

UA researcher aims to identify imaging biomarkers for effective screening of ovarian cancer

University of Arizona researcher Jennifer Barton is leading a two-year, $1 million project funded by the National Cancer Institute to identify imaging biomarkers of ovarian cancer, the most deadly gynecological cancer in the United States.

1 Jun 2016

Experts discuss new insights into early stages of Parkinson’s disease at EAN Congress

Early diagnosis and starting treatment as early as possible are decisive factors in achieving improved quality of life for Parkinson's sufferers. Experts are discussing a wide range of new insights into the early stages of the disease at the Congress of the European Academy of Neurology in Copenhagen.

31 May 2016

Axumin approved for use in PET scans in patients with recurrent prostate cancer

The U.S. Food and Drug Administration today approved Axumin, a radioactive diagnostic agent for injection. Axumin is indicated for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence based on elevated prostate specific antigen (PSA) levels following prior treatment.

28 May 2016

Nanoparticles of ultrapure silicon act as luminescent markers in early diagnosis of cancer

The group of Russian and French researchers, with the participation of scientists from the Lomonosov Moscow State University, has succeeded to synthesize nanoparticles of ultrapure silicon, which exhibited the property of efficient photoluminescence, i.e., secondary light emission after photoexcitation.

22 May 2016

Carol Fabian inducted into KU Women's Hall of Fame for contributions to breast cancer research

Among the women inducted into the University of Kansas Hall of Fame on April 14, 2016, was Carol Fabian, MD. Fabian, a professor of medicine at the University of Kansas Medical Center and director of the Breast Cancer Prevention Center at The University of Kansas Cancer Center, is a nationally recognized oncologist and a pioneer in in the field of breast cancer research.

17 May 2016

Clinical study shows sitagliptin drug not effective in treating NAFLD

A diabetes medication described in some studies as an effective treatment for nonalcoholic fatty liver disease (NAFLD) works no better than a placebo, report researchers at University of California San Diego School of Medicine, after conducting the first randomized, double-blind, controlled clinical trial of sitagliptin, an oral antihyperglycemic marketed by Merck & Co. under the name Januvia.

13 May 2016

Vessel-sparing radiation, better understanding of prostate anatomy can improve quality of life

Remember the game Operation? You need to carefully remove the body part without nicking the sides or the buzzer will sound.

12 May 2016

New IsoPSA test identifies molecular structural changes in protein biomarkers to detect prostate cancer

A promising new test is detecting prostate cancer more precisely than current tests, by identifying molecular changes in the prostate specific antigen (PSA) protein, according to Cleveland Clinic research presented today at the American Urological Association annual meeting.

12 May 2016

Celiac disease more common among Americans with Punjabi ancestry, study shows

About 1.8 million Americans have celiac disease, an immune-based condition brought on by the consumption of gluten in genetically susceptible patients. Among patients diagnosed with celiac disease by small intestinal biopsy in the U.S., those from the Punjab region of India have the highest rates of disease, according to new research published in Clinical Gastroenterology and Hepatology,1 the official clinical practice journal of the American Gastroenterological Association.

10 May 2016

Experimental therapy stops glioblastoma, high-grade gliomas in human cells and mouse models

Researchers report in the journal Cancer Cell an experimental therapy that in laboratory tests on human cells and mouse models stops aggressive, treatment-resistant and deadly brain cancers called glioblastoma and high-grade gliomas.

10 May 2016

Medicare policy puts low-income Americans at increased risk for colorectal cancer

Colorectal cancer is the second highest cause of cancer death in the United States, expected to claim the lives of an estimated 49,190 people in 2016. The Affordable Care Act aimed to increase access to CRC screening by not holding patients responsible for all costs of the procedure, yet current Medicare insurance beneficiaries lacking supplemental insurance may not be able to afford colon cancer screening and treatment.

9 May 2016

Teledermatology improves patients' access to dermatologists

Teledermatology significantly improved access to specialized skin care for a group of patients that traditionally has limited options, according to an independent study led by researchers at the RAND Corporation and Harvard Medical School's Department of Health. The findings appear in a JAMA Dermatology article published online May 4.

6 May 2016

Barrow research focuses on use of new technology for imaging brain tumors

Scientists at Barrow Neurological Institute have recently made discoveries about use of a new technology for imaging brain tumors in the operating room -- a finding that could have important implications for identifying and locating invading cells at the edge of a brain tumor.

5 May 2016

Liposuction to manage lymphedema? An interview with Professor John Boyages

Lymphedema is persistent swelling of the arm and/or hand following biopsy or treatment of the axillary lymph nodes for patients with breast cancer. It is due to excess accumulation of protein‐rich fluid in body tissues.

4 May 2016

Combination of two diagnostic tests can decrease chance of missing tumors by sevenfold

Cytopathology researchers at Houston Methodist Hospital recently found that combining two diagnostic tests, Pap and high-risk human papillomavirus (hrHPV), dramatically decreased the chance of missing tumors and high-grade lesions by sevenfold.

4 May 2016

First-ever ACR-led imaging boot camp training for breast radiologists to be held in Jeddah

The American College of Radiology is partnering with GE Healthcare and King Faisal Specialist Hospital & Research Center to bring the first-ever ACR-led imaging boot camp training for breast radiologists to the Middle East. The three-day Breast Imaging Boot Camp to be held May 23-25 in Jeddah will provide up to 40 practicing radiologists in Saudi Arabia and the Middle East with intensive hands-on experience in mammography and breast ultrasonography.

4 May 2016

New research reveals sliding ability of cancer cells that helps in tumor spread

Metastasis. The very word evokes fear. Defined as the spread of cancer cells from one part of the body to another, metastasis is the cause of approximately 90 percent of deaths among cancer patients. How does metastasis come about? And can we stop it? New research from a team led by Northeastern's Anand Asthagiri, associate professor of bioengineering and chemical engineering, helps to answer those questions. It provides an astonishing look at the biophysical properties that permit breast cancer cells to "slide" by obstales and travel out of their primary tumor toward a blood vessel that will carry them to a new site.

29 Apr 2016

Protea signs license agreement with Yale to develop new technology for detecting malignant melanoma

Protea Biosciences Group, Inc. announced today that it had entered into an exclusive license agreement with Yale University for new technology to improve the differential diagnosis of malignant melanoma.

27 Apr 2016

Hormonal contraception may increase susceptibility of women to genital infection

Women account for approximately half of all individuals living with HIV worldwide, and researchers wanted to identify the risk factors that increase susceptibility of women to genital infection.

20 Apr 2016

Biopsy News and Research

Further Reading

Clinical trial to evaluate ability of MRI to improve prostate cancer diagnosis

UA researcher aims to identify imaging biomarkers for effective screening of ovarian cancer

Experts discuss new insights into early stages of Parkinson’s disease at EAN Congress

Axumin approved for use in PET scans in patients with recurrent prostate cancer

Nanoparticles of ultrapure silicon act as luminescent markers in early diagnosis of cancer

Carol Fabian inducted into KU Women's Hall of Fame for contributions to breast cancer research

Clinical study shows sitagliptin drug not effective in treating NAFLD

Vessel-sparing radiation, better understanding of prostate anatomy can improve quality of life

New IsoPSA test identifies molecular structural changes in protein biomarkers to detect prostate cancer

Celiac disease more common among Americans with Punjabi ancestry, study shows

Experimental therapy stops glioblastoma, high-grade gliomas in human cells and mouse models

Medicare policy puts low-income Americans at increased risk for colorectal cancer

Teledermatology improves patients' access to dermatologists

Barrow research focuses on use of new technology for imaging brain tumors

Liposuction to manage lymphedema? An interview with Professor John Boyages

Combination of two diagnostic tests can decrease chance of missing tumors by sevenfold

First-ever ACR-led imaging boot camp training for breast radiologists to be held in Jeddah

New research reveals sliding ability of cancer cells that helps in tumor spread

Protea signs license agreement with Yale to develop new technology for detecting malignant melanoma

Hormonal contraception may increase susceptibility of women to genital infection

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News